Infliximab (chimeric anti-tumour necrosis factor a monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial, Lancet, vol.354, pp.1932-1971, 1999. ,
Randomised doubleblind comparison of chimeric monoclonal antibody to tumour necrosis factor, Lancet, vol.344, p.8930, 1994. ,
,
, Adalimumab, a fully human antitumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial, Arthritis Rheum, vol.48, pp.35-45, 2003.
Therapeutic effect of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double blind randomized controlled trial, Lancet, vol.363, pp.675-81, 2004. ,
Relative efficiencies of the 7 rheumatoid arthritis Core Data Set measures to distinguish active from control treatments in 9 comparisons from clinical trials of 5 agents, Clin Exp Rheumatol, vol.32, issue.5, pp.47-54, 2014. ,
The comparative safety of tumor necrosis factor inhibitors in rheumatoid arthritis: a meta-analysis update of 44 trials, Am J Med, vol.127, pp.1208-1240, 2014. ,
Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with inadequate response to conventional DMARDs-a systematic review and network meta-analysis, Health Qual Life Outcomes, vol.12, p.102, 2014. ,
Do patients with older-onset rheumatoid arthritis receive less aggressive treatment?, Ann Rheum Dis, vol.65, pp.1226-1235, 2006. ,
Observational cross-sectional study revealing less aggressive treatment in Japanese elderly than nonelderly patients with rheumatoid arthritis, J Clin Rheumatol, vol.16, pp.370-374, 2010. ,
Leflunomide Treatment in Elderly Patients with Rheumatoid or Psoriatic Arthritis; Retrospective Analysis of Safety and Adherence to Treatment, Drugs Aging, vol.26, pp.395-402, 2009. ,
Disease-Modifying Antirheumatic Drug Use in the Elderly Rheumatoid Arthritis Patient, Clin Geriatr Med, vol.21, pp.649-69, 2005. ,
Tumour necrosis factor-alpha antagonists in the management of rheumatoid arthritis in the elderly: a review of their efficacy and safety, Drugs Aging, vol.26, pp.647-64, 2009. ,
Rheumatoid Arthritis in the Elderly in the Era of Tight Control Rheumatoid Arthritis in the Elderly in the Era of Tight Control, Drugs Aging, vol.30, pp.863-69, 2013. ,
Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis, J Rheumatol, vol.33, pp.234-277, 2006. ,
Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients. Rheumatology (Oxford), vol.48, pp.1575-80, 2009. ,
6 auteurs al. Response to etanercept (Enbrel_) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results, J Rheumatol, vol.30, pp.691-96, 2003. ,
Van der Heijde D, 6 auteurs al. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis, J Rheumatol, vol.33, pp.234-277, 2006. ,
Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-? antagonists in France? The CORPUS cohort study, Clin Exp Rheumatol, vol.33, pp.602-612, 2015. ,
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, vol.31, pp.315-339, 1988. ,
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, Arthritis Rheum, vol.38, pp.44-52, 1995. ,
Measurement of patient outcome in arthritis, Arthritis Rheum, vol.23, pp.137-182, 1980. ,
QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries, Ann Rheum Dis, vol.66, pp.1491-96, 2007. ,
Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study, Arthritis Res Ther, vol.11, p.7, 2009. ,
Cardiovascular risk induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review, Jt Bone Spine Rev Rhum, vol.78, pp.23-30, 2011. ,
Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNF? inhibitors and rituximab, Ann Rheum Dis, vol.74, pp.415-436, 2015. ,
Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE), Rheumatology (Oxford), vol.54, pp.798-807, 2015. ,